Structure

InChI Key DDLIGBOFAVUZHB-UHFFFAOYSA-N
Smile Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2
InChI
InChI=1S/C18H13ClFN3/c1-11-21-9-13-10-22-18(14-4-2-3-5-16(14)20)15-8-12(19)6-7-17(15)23(11)13/h2-9H,10H2,1H3

Physicochemical Descriptors

Property Name Value
Molecular Formula C18H13ClFN3
Molecular Weight 325.77
AlogP 4.32
Hydrogen Bond Acceptor 3.0
Hydrogen Bond Donor 0.0
Number of Rotational Bond 1.0
Polar Surface Area 30.18
Molecular species NEUTRAL
Aromatic Rings 3.0
Heavy Atoms 23.0

Pharmacology

Action Mechanism of Action Reference
POSITIVE ALLOSTERIC MODULATOR GABA-A receptor; anion channel positive allosteric modulator ISBN Wikipedia Wikipedia Wikipedia

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Epilepsy 4 D004827 ClinicalTrials
Amnesia 4 D000647 ClinicalTrials
Fractures, Bone 3 D050723 ClinicalTrials
Depressive Disorder 3 D003866 ClinicalTrials
Postoperative Nausea and Vomiting 3 D020250 ClinicalTrials
Liver Cirrhosis 3 D008103 ClinicalTrials
Brain Injuries 3 D001930 ClinicalTrials
Hemorrhage 3 D006470 ClinicalTrials
Anxiety 3 D001007 ClinicalTrials
Fluoride Poisoning 3 D005458 ClinicalTrials
Breech Presentation 3 D001946 ClinicalTrials
Hypertension 3 D006973 ClinicalTrials
Schizophrenia 3 D012559 ClinicalTrials
Infertility 3 D007246 ClinicalTrials
Delirium 3 D003693 ClinicalTrials
Respiratory Insufficiency 3 D012131 ClinicalTrials
Multiple Sclerosis, Relapsing-Remitting 3 D020529 ClinicalTrials
Wounds and Injuries 3 D014947 ClinicalTrials
Dementia 3 D003704 ClinicalTrials
Shock, Septic 3 D012772 ClinicalTrials
Pain 3 D010146 ClinicalTrials
Borderline Personality Disorder 2 D001883 ClinicalTrials
Obsessive-Compulsive Disorder 2 D009771 ClinicalTrials
Tuberculosis, Pulmonary 2 D014397 ClinicalTrials
Aggression 2 D000374 ClinicalTrials
Tonsillitis 2 D014069 ClinicalTrials
Hypotension 2 D007022 ClinicalTrials
Subarachnoid Hemorrhage 2 D013345 ClinicalTrials
Bipolar Disorder 2 D001714 ClinicalTrials
Fractures, Multiple 2 D000069076 ClinicalTrials
Depressive Disorder, Treatment-Resistant 2 D061218 ClinicalTrials
Depressive Disorder, Major 2 D003865 ClinicalTrials
Breast Neoplasms 2 D001943 ClinicalTrials
Stress Disorders, Post-Traumatic 2 D013313 ClinicalTrials
Breast Neoplasms 2 D001943 ClinicalTrials
Urogenital Neoplasms 2 D014565 ClinicalTrials
Ischemic Stroke 2 D000083242 ClinicalTrials
Seizures 2 D012640 ClinicalTrials
Muscular Atrophy, Spinal 1 D009134 ClinicalTrials
Respiratory Syncytial Virus Infections 1 D018357 ClinicalTrials
Psoriasis 1 D011565 ClinicalTrials
Chronic Pain 1 D059350 ClinicalTrials
Cough 1 D003371 ClinicalTrials
Neck Pain 1 D019547 ClinicalTrials
Influenza, Human 1 D007251 ClinicalTrials
Renal Insufficiency 1 D051437 ClinicalTrials
Low Back Pain 1 D017116 ClinicalTrials
Fatigue 1 D005221 ClinicalTrials
Prostatic Neoplasms, Castration-Resistant 1 D064129 ClinicalTrials
Cardiovascular Diseases 1 D002318 ClinicalTrials
Colitis, Ulcerative 1 D003093 ClinicalTrials
Obesity 1 D009765 ClinicalTrials
Mitochondrial Diseases 1 D028361 ClinicalTrials
Suicidal Ideation 1 D059020 ClinicalTrials
Gastrointestinal Stromal Tumors 1 D046152 ClinicalTrials
Alzheimer Disease 1 D000544 ClinicalTrials
Amyotrophic Lateral Sclerosis 1 D000690 ClinicalTrials
Dermatitis, Atopic 1 D003876 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials
Crohn Disease 1 D003424 ClinicalTrials
Infections 1 D007239 ClinicalTrials
Mesothelioma 1 D008654 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials
Prostatic Neoplasms 1 D011471 ClinicalTrials
Psoriasis 1 D011565 ClinicalTrials
Arthritis, Rheumatoid 1 D001172 ClinicalTrials
Skin Diseases 1 D012871 ClinicalTrials
HIV Infections 1 D015658 ClinicalTrials
Endometriosis 1 D004715 ClinicalTrials
Diabetes Mellitus, Type 2 1 D003924 ClinicalTrials
Multiple Myeloma 1 D009101 ClinicalTrials
Cocaine-Related Disorders 1 D019970 ClinicalTrials
Hepatitis C 1 D006526 ClinicalTrials
Carcinoma, Non-Small-Cell Lung 1 D002289 ClinicalTrials
Heart Failure 1 D006333 ClinicalTrials
Osteoporosis, Postmenopausal 1 D015663 ClinicalTrials
Substance-Related Disorders 1 D019966 ClinicalTrials
Atherosclerosis 1 D050197 ClinicalTrials
Hepatitis C, Chronic 1 D019698 ClinicalTrials
Hepatitis B, Chronic 1 D019694 ClinicalTrials
Anemia 1 D000740 ClinicalTrials
Psychotic Disorders 1 D011618 ClinicalTrials
Communicable Diseases 1 D003141 ClinicalTrials
Lymphoma, Non-Hodgkin 1 D008228 ClinicalTrials
Nausea 1 D009325 ClinicalTrials
Aspergillosis 1 D001228 ClinicalTrials
Non-alcoholic Fatty Liver Disease 1 D065626 ClinicalTrials
Sepsis 1 D018805 ClinicalTrials
Tuberculosis 1 D014376 ClinicalTrials
Leukemia, Myeloid, Acute 1 D015470 ClinicalTrials
Parkinson Disease 1 D010300 ClinicalTrials
Melanoma 1 D008545 ClinicalTrials
Tobacco Use Disorder 1 D014029 ClinicalTrials
Leukemia, Lymphocytic, Chronic, B-Cell 1 D015451 ClinicalTrials
Myositis Ossificans 1 D009221 ClinicalTrials
Pruritus 0 D011537 ClinicalTrials

Related Entries

MCS

Scaffolds

Salt

Side Effects from Label

Side effects Relative Frequency (%) Labels
Gastrointestinal disorders Vomiting 31.0
Gastrointestinal disorders Nausea 14.0
Gastrointestinal disorders Vomiting 11.0
Respiratory, thoracic and mediastinal disorders Hypoxia 9.0
Gastrointestinal disorders Vomiting 8.0
General disorders and administration site conditions Tenderness 7.0
General disorders and administration site conditions Injection site pain 6.2
Nervous system disorders Agitation 6.0
Respiratory, thoracic and mediastinal disorders Laryngospasm 6.0
Gastrointestinal disorders Nausea 6.0
General disorders and administration site conditions Tenderness 5.6
Gastrointestinal disorders Hiccups 5.5
General disorders and administration site conditions Injection site pain 5.0
Investigations Pulmonary function test decreased 5.0
Nervous system disorders Respiratory depression 5.0
Respiratory, thoracic and mediastinal disorders Rhonchi 5.0
Cardiac disorders Bradycardia 4.0
Gastrointestinal disorders Nausea 4.0
Respiratory, thoracic and mediastinal disorders Obstructive airways disorder 4.0
Gastrointestinal disorders Hiccups 3.9
Skin and subcutaneous tissue disorders Erythema 3.8
General disorders and administration site conditions Injection site pain 3.7
General disorders and administration site conditions Pain 3.7
Gastrointestinal disorders Nausea 3.0
Gastrointestinal disorders Vomiting 2.9
Gastrointestinal disorders Nausea 2.8
Skin and subcutaneous tissue disorders Erythema 2.6
Gastrointestinal disorders Vomiting 2.6
Nervous system disorders Agitation 2.0
Skin and subcutaneous tissue disorders Dermatitis 2.0
Cardiac disorders Extrasystoles 2.0
Respiratory, thoracic and mediastinal disorders Hypoxia 2.0
Respiratory, thoracic and mediastinal disorders Laryngospasm 2.0
Respiratory, thoracic and mediastinal disorders Obstructive airways disorder 2.0
Investigations Pulmonary function test decreased 2.0
Skin and subcutaneous tissue disorders Rash 2.0
Nervous system disorders Respiratory depression 2.0
Respiratory, thoracic and mediastinal disorders Rhonchi 2.0
Nervous system disorders Sedation 2.0
Cardiac disorders Ventricular extrasystoles 2.0
Respiratory, thoracic and mediastinal disorders Cough 1.9
General disorders and administration site conditions Induration 1.9
General disorders and administration site conditions Induration 1.7
Nervous system disorders Headache 1.5
Gastrointestinal disorders Nausea 1.5
Respiratory, thoracic and mediastinal disorders Cough 1.3
Nervous system disorders Headache 1.3
Nervous system disorders Somnolence 1.3
Nervous system disorders Somnolence 1.2
Nervous system disorders Agitation 1.0
Cardiac disorders Bradycardia 1.0
Skin and subcutaneous tissue disorders Dermatitis 1.0
Cardiac disorders Extrasystoles 1.0
Respiratory, thoracic and mediastinal disorders Obstructive airways disorder 1.0
Investigations Pulmonary function test decreased 1.0
Skin and subcutaneous tissue disorders Rash 1.0
Nervous system disorders Respiratory depression 1.0
Respiratory, thoracic and mediastinal disorders Rhonchi 1.0
Nervous system disorders Sedation 1.0
Cardiac disorders Ventricular extrasystoles 1.0
Gastrointestinal disorders Hiccups 0.9
Gastrointestinal disorders Vomiting 0.758
Gastrointestinal disorders Vomiting 0.756
Respiratory, thoracic and mediastinal disorders Laryngospasm 0.752
Infections and infestations Nasopharyngitis 0.752
Respiratory, thoracic and mediastinal disorders Rhinorrhoea 0.752
Respiratory, thoracic and mediastinal disorders Sneezing 0.752
Gastrointestinal disorders Vomiting 0.752
Gastrointestinal disorders Nausea 0.504
Skin and subcutaneous tissue disorders Erythema 0.5
General disorders and administration site conditions Induration 0.5
Vascular disorders Phlebitis 0.5
Vascular disorders Phlebitis 0.4
Musculoskeletal and connective tissue disorders Musculoskeletal stiffness 0.3
Respiratory, thoracic and mediastinal disorders Laryngospasm 0.252
Infections and infestations Nasopharyngitis 0.252
Respiratory, thoracic and mediastinal disorders Rhinorrhoea 0.252
Respiratory, thoracic and mediastinal disorders Sneezing 0.252

Cross References

Resources Reference
CAS NUMBER 59467-70-8
ChEBI 6931
ChEMBL CHEMBL655
DrugBank DB00683
DrugCentral 1802
EPA CompTox DTXSID5023320
FDA SRS R60L0SM5BC
Human Metabolome Database HMDB0014821
Guide to Pharmacology 3342
KEGG C07524
PDB 08J
PharmGKB PA450496
PubChem 4192
SureChEMBL SCHEMBL35061
ZINC ZINC000095626706